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College of Medicine, Bronx, New YorkABSTRACT Sickle hemoglobin (HbS) is a point mutation of the two b subunits in normal Hb (HbA) that leads to nucleated poly-
merization and accompanying pathology. We measured the rates of homogeneous and heterogeneous nucleation of HbS in the
presence of up to 50% HbA under conditions in which hybrid HbAS molecules will also form. The replacement of 50% of HbS by
HbA slows polymerization by factors of ~100 in the physiological range, which is substantially less than previously thought. To
provide a theoretical description of these data, we extended the double nucleation model for HbS polymerization to conditions in
which hybridized mixtures are present. Measurements of homogeneous nucleation and the theory agree only when at least one
of the molecules in the nucleus is not a hybrid. We attribute this to the necessary presence in the nucleus of a molecule that
utilizes both b-subunit mutation sites in intermolecular contacts, whereas the remaining molecules engage only one of the muta-
tion sites. Heterogeneous nucleation appears to require an even greater number of nonhybrid molecules, presumably because
of the need for the nucleus to attach to the polymer as well as to form internal bonds. These results also provide insights into the
pathophysiology of sickle cell disease, including the occasional severe events that strike persons in whom both HbS and
HbA are expressed, a condition known as sickle trait. The studies reported here are necessary for understanding physiologically
relevant polymerization in the presence of ligands as well as therapeutically relevant copolymerizing inhibitors.INTRODUCTIONSickle cell disease is a major global health problem. About
100,000 individuals in the United States have sickle cell
disease (1,2), and this number of cases is added every
6 months in Africa (3). This disease, which manifests itself
episodically in painful crises, shortens an individual’s life-
span as a result of chronic organ damage even in highly
developed areas with excellent medical care. In less devel-
oped parts of the world, it can lead to death in early child-
hood (4). When either normal hemoglobin (HbA) or fetal
Hb (HbF) is mixed with sickle Hb (HbS), the resulting
combination ameliorates the disease, providing a de facto
model for the effects of agents (drugs or genetic modifica-
tion) that would prevent sickling. Nonetheless, dramatic
fatalities have been reported in the case of individuals
undergoing strenuous conditioning (such as athletes or mili-
tary recruits) who possess only sickle cell trait, a condition
in which one parent contributes a gene for HbS and the other
parent contributes a gene for HbA (5,6). This is all the more
shocking considering that trait individuals are normally
asymptomatic (7). It is also of concern given that sickle trait
incidence is much greater than that of sickle cell disease
itself, viz. 300 million individuals with trait worldwide (8).
The molecular genesis of sickle cell disease is a mutation
on the two b-subunits of the Hb tetramer. The replacement
of b6 Glu/Val creates a hydrophobic surface protrusion
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0006-3495/11/12/2790/8 $2.00a partner molecule and generate long, stiff polymers that
underlie the pathology of the disease. The polymers are
made of seven double strands that have axial and lateral con-
tacts. The amino acids that form axial contacts are present in
both HbA and HbS, whereas the donor portion of the lateral
contacts is unique to HbS, being the location of the b6 muta-
tion. Although these contacts are present at all times on the
molecular surface, the axial and lateral contacts cannot work
together to create a regular structure unless the Hb molecule
is in its deoxy or T quaternary structure (the arrangement of
the four subunits that the molecule assumes when it carries
no ligands). HbA has the same axial contacts as HbS;
however, because of the high energetic cost of burying a
charged glutamic acid in the hydrophobic lateral receptor
region, it does not form polymers (9–12).
It is also possible to have Hb hybrid molecules. Hb a2b2
tetramers spontaneously split into ab dimer pairs, and they
do so more easily in the R-structure (which Hb prefers when
ligands are present) than in the T quaternary structure.
Mixtures of liganded HbS and HbA will therefore readily
create hybrid species (a2b
SbA). These hybrids are also
capable of entering sickle polymers, but with a reduced pro-
bability relative to pure HbS tetramers. If polymers were
equivalent to crystals, the probability of incorporation of
hybrids would be 50%. However, the fact that hybrids enter
into polymers with a lower likelihood suggests that two of
the 14 strands in each polymer simultaneously make use
of both lateral contacts, and a structural model that rational-
izes the observed probability has been proposed (13).
Sickle cell disease is fundamentally a kinetic phenom-
enon (14). Polymerization is reversible upon reoxygenationdoi: 10.1016/j.bpj.2011.10.027
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when red cells pass through narrow regions in the microvas-
culature, such as capillaries or diminished lumen around
adherent cells in postcapillary venules (15). This is also
the region in the circulation where cells deliver their oxygen
and become polymerization-competent. Strategies that
delay the exponentially abrupt onset of polymer formation
provide opportunities for therapy even when polymerization
is still thermodynamically possible (16). This has motivated
extensive studies of the kinetics of polymerization. One
outcome of such studies was the discovery that polymers
form by a double (homogeneous and heterogeneous) nu-
cleation mechanism, and a thermodynamically grounded
approach to this kinetic mechanism was shown to be re-
markably successful (17).
To date, only a single study has focused on the poly-
merization kinetics of sickle trait under near-physiological
conditions (18), and that study was undertaken before
methods became available to access the physiologically rele-
vant regions of high concentrations and short delay times (in
the range of seconds rather than minutes). Thus, we thought
it timely and appropriate to make detailed measurements.
With the data in hand, we addressed two questions:
1. Could the double nucleation model be suitably extended
to account for copolymerizing Hb species, and would
any new insights into the polymerization process
emerge?
2. Would the combination of data and model provide
insights into the pathophysiology of sickle cell disease
and sickle trait?
Although it was not the focus of this work, it is worth
noting that polymerization kinetics that include species
with reduced polymerization probability will necessarily
provide insights into the polymerization of partially oxygen-
ated HbS (the dominant in vivo condition), and polymeriza-
tion in the presence of nonsaturating amounts of antisickling
drugs.MATERIALS AND METHODS
We prepared HbA and HbS in 0.15M phosphate buffer, pH 7.35, using stan-
dard column chromatography methods (19). We determined the concentra-
tions by observing the Soret absorbance and fitting it to the sum of standard
spectra. Hamilton syringes and micropipets were used to mix the samples.
Sodium dithionite was added to achieve a final concentration of 0.55 M
before kinetic measurements were obtained.
Some samples were mixed and used at once, and other samples were
mixed and stored in liquid nitrogen until required. In all cases, the storage
history of the samples was noted. When we compared the results, we found
that the samples that were stored in nitrogen systematically differed from
the samples that were used at once. Moreover, the nitrogen-stored samples
differed more from each other than did those that were used promptly.
Previously, samples stored in liquid nitrogen showed behavior consistent
with that observed in samples used promptly, although concentration mea-
surements were always made on such samples (none of which were Hb
mixtures) before use. We hypothesize that the composition of the samplesstored in nitrogen was changed by the storage process. This could occur, for
example, if the HbS were less stable than HbA, such that storage would
increase the A/S ratio. Indeed, changing the A/S ratio of these samples
was sufficient to make all concentrations consistent with the unfrozen
data. The data described in the results, however, are restricted to samples
that were not stored in liquid nitrogen.
Samples for kinetic measurements were prepared in a glove box flushed
with humidified CO. We prepared sample slides a few micrometers thick by
placing a small drop a few microliters in volume on a coverslip and sealing
it with a smaller coverslip using dental wax.
We determined the kinetics by using laser photolysis to generate
deoxyHb on a large array of spots imaged on the slides (20). The light scat-
tering from each spot then allowed us to observe the kinetics as a function of
time. Light scattered by each spot grew exponentially, and the exponential
coefficient is denoted B, a parameter that is related to heterogeneous nucle-
ation (17). We determined B by fitting the first 10% of the growth of light
scattering to an exponential function. The distribution of the onset times
(delay times) of the growth curves is described by an equation deter-
mined by Szabo (21), from which the homogeneous nucleation rate f is
determined.Model
The model involves a statistical mechanics/thermodynamics description of
the concentration of nuclei, which is experimentally deduced from the
measured rate of nucleation. Despite being simple in concept, the model
has shown an ability to describe nucleation rates over many orders magni-
tude with parameters that are quite reasonable. To include the effects of
HbA mixed with HbS, one must distinguish the number of polymerization-
competent species from the total concentration of Hb. Additionally, as
aggregates of various composition are described, one must consider the
entropy that accompanies the varied compositional arrangements that
become possible.
To compute the nucleation rates, we employ equilibrium nucleation
theory (22). This assumes that the rate of nucleation is proportional to
the concentration of nuclei, expressed as an equilibrium between nuclei
and monomers. The equilibrium constant can in turn be expressed in terms
of fundamental energetic terms (17). Calculation of the energies that hold
the hybrids in place in the polymer is particularly simple. For HbAS
hybrids, the only change from HbS molecules involves one of the possible
lateral contact sites. Moreover, the energetic difference at that site is so
great as to force the hybrid to engage only the Val site in the receptor region.
Therefore, the only differences will come from entropic considerations of
restricting the possible configurations due the need to use only the right
orientation of the hybrid molecules. This involves computing the number
of ways in which such correctly oriented molecules can be chosen.
The basis of the nucleation calculation is described in detail in Ferrone
et al. (17) and will not be reproduced here. It is important to recognize
that nucleus size is a thermodynamic construct, and therefore it will be
changed when the rate constants are calculated for hybrids.
We compute the equilibrium by equating the chemical potentials of
monomers and aggregates. In previous descriptions an aggregate could be
described by one index, its size N.Now the aggregate contains Nmolecules,
of which M are hybrids. The solution chemical potential will then be
m ¼ NmRT þ ðN MÞRT ln gcð1 XÞ2
þ M RT ln gcð1 XÞ2X; (1)
where mRT is the rotational and translational chemical potential, which is the
same for hybrid or pure HbS; g is the activity coefficient, which is a function
of the total monomer concentration, c; and X is the net fraction of HbA
irrespective of its distribution. The terms multiplying c come from binomial
coefficients for HbS and HbAS, respectively (23). R is the gas constant, and
T is the absolute temperature.Biophysical Journal 101(11) 2790–2797
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be modified by the addition of an entropic term. If CM
N is the number of
ways M molecules can be arranged within the group of N, then
CNM ¼
N!
M!ðN MÞ! (2)
and this will be included as a term –RT ln CM
N. The chemical potential
equality must be solved for nucleus sizes, and if this can be done analyti-
cally, the results can be extremely powerful. Therefore, we used a form
of Stirling’s approximation (24) to account for ln N! terms, viz:
ln N! ¼

N þ 1
2

ln N  N þ 1
2
ln 2p: (3)
This is more accurate when N is small compared with the more familiar
NlnN. Finally, we consider a situation in which some number k of the mole-
cules in the nucleus are obliged to be HbS. This leaves the hybrids to
distribute themselves among a smaller collection, N0 ¼ N–k.
It might be speculated that even though an incorrect orientation entails an
energetic penalty, the number of ways this could happen might offset the
penalty by entropic benefit. A calculation of this effect shows that only
very small energetic penalties could be so offset, and therefore any hybrids
within the nucleus can be viewed as oriented in their most favorable
arrangement.
Previously, the nucleus was determined by taking the size-derivative
d/dN of the concentration of aggregates and setting it to zero to find the
turning point in the aggregate concentration. The value of N at that point
is the nucleus size, N*. With two variables, two derivatives are required.
First it is necessary to take the derivative v/vM to find the most likely value
of M, denotedM*.With this chosen, then v/vN is taken to find the nucleus.
When N is large and the usual form of Stirling’s approximation can be
used, it is straightforward to solve for M* with the result that
M ¼ XN: (4)
With the extended form of Stirling’s formula, the above solution is no
longer exact. It is, however, an approximate solution, which is exact at
X ¼ 0.5. Its accuracy is sufficient to allow its continued usage here. This
then permits the nucleus size to be calculated.
For pure HbS, the nucleus was found to be given by a particularly simple
equation (17):
N ¼ x
ln S
; (5)
where S is the activity supersaturation and x is a constant. If the total
concentration is c, the solubility is cs, and the activity coefficients are
respectively g and gs, then S h gc/gscs and the constant x is given by
x h –4 – mPC/RT, where mPC is the average energy of the contacts that
hold monomers in their lattice positions in the polymer.
With the modifications described above, the nucleus size in the mixtures
is readily found to be
N ¼
x 1
2
ð1 ln½Xð1 XÞÞ
ln½Sð1 XÞ : (6)
Note that the supersaturation S still refers to total concentration and solu-
bility in pure HbS solutions (not in the mixture). The form of Eq. 6 for
homogeneous nucleus is still similar to Eq. 5, given the replacements
x/ x–1/2(1–ln[X(1–X)]) and S/ S(1–X).
The nucleation rate is proportional to the concentration of nuclei, which
involves not only the stoichiometry dictated by the nucleus size but also theBiophysical Journal 101(11) 2790–2797equilibrium constant of the reaction. The equilibrium constant for forming
nuclei (and thus the overall rate of nucleation) is modified beyond the
alteration in N*. Whereas the nucleus activity was previously written as
gN*cN* ¼ KN*(gc)N*, it now can be written as
gNcN ¼
ð1 XÞ
2X
k
KN ½gcð1 XÞN

: (7)
where k is the number of pure HbS molecules required to be a part of the
nucleus (here, it turns out that in the homogeneous nucleus, k ¼ 1). The
form and construction of K are as previously described (17) except that
the replacement of the constant x must be included. N* of course is the
modified version.
Heterogeneous nucleation is described analogously. Within the heteroge-
neous nucleation process there is a constant denoted 4 that describes the
probability of attachment of a heterogeneous nucleus. This is modified to
become 4(1–X)l, where l designates the number of molecules of HbS
required at the attachment site.RESULTS
We measured kinetics by laser photolysis of the CO deriva-
tive for mixtures of 30%, 40%, and 50% HbA with HbS at
25C over a range of concentrations from 4.4 to 5.9 mM
(28.1–37.9 g/dl). Fig. 1 shows the homogeneous nucleation
rate (fo) and the exponential growth rate (B) for 25
C and
50% HbA for two different experiments (open symbols),
compared with results for HbS itself (solid symbols).
When the formation of polymers is observed as a function
of time, there is an apparent delay between initiation and
the time when polymers are seen, which is a consequence
of the exponential growth process. This delay time has
been used as an empirical characterization of polymeriza-
tion. Because B is the composite rate appearing in the expo-
nential, changes in the delay time derive primarily from
a variation in B. As can be seen from Fig. 1 b, the values
of B and thus the delay times for 50% mixtures are roughly
a factor of 100 slower than HbS in the range studied, and the
difference rises for lower values of concentration.
Note that if there were simply 50% fewer molecules in the
solution, the values of the abscissa would move 0.3 to the
left, which is more than the entire scale of the graph. If
instead one were to postulate that HbS and HbAS could
equally polymerize, this would mean that only 75% of the
molecules could participate in polymers. This would call
for moving abscissa values to the left by 0.12. For example,
polymerization of 50:50 mixtures at log10(c) ¼ 0.75 should
actually behave as 0.63, which is close to what is observed.
This description is overly simplistic for two unavoidable
reasons: First, the remaining 25% of species that do not
polymerize nonetheless serve to crowd the solution, in-
creasing the rate in ways that are well known and described.
Second, there are clearly two arrangements of an HbS mole-
cule that could satisfy the constraints that only one arrange-
ment of HbAS molecules can achieve in the polymer
or aggregate. Thus, there are effectively fewer HbAS spe-
cies than we considered above. Evidently, the effects of
FIGURE 1 Homogeneous nucleation rate (fo) and the exponential growth
rate (B) for 25C and 50% HbA for two different experiments (open
symbols), compared with results for HbS itself (solid symbols). The solid
line through the 50% fo data represents the theory that one molecule of
the homogeneous nucleus is required to be nonhybridized HbS. The hetero-
geneous process requires three additional nonhybrid molecules (e.g., in the
polymer side of the contact regions). The dashed line shows the result of
requiring only a single molecule of HbS, as is required in the homogeneous
process.
Nucleation of Sickle Hemoglobin Mixtures 279325% crowding and the effects of fewer HbAS species are
close to canceling in this case.
To describe the data in a more detailed way, we modify
the double nucleation model as described above and draw
the prediction of the theory as a solid line, on the basis of
requiring one molecule per homogeneous nucleus to be
pure HbS. As can seen, the agreement is quite good. In
the absence of such a requirement, the model fails to
describe the data shown here. Moreover, in separate exper-
iments in which AS hybrids were cross-linked, the nucle-ation rates (fo) and exponential growth rates (B) were
much slower than seen here.
When only one molecule is restricted to be HbS for
heterogeneous nucleation, the agreement of B is not as
good. This is shown by the dashed line in Fig. 1. However,
the restriction may also apply to the polymer providing
attachment sites. When the net number of attachment sites
and pure HbS molecules in the aggregate is 4, good agree-
ment results as shown in Fig. 1.
For further comparison of the theory and experiment,
we constructed a correlation graph with data for 0%, 30%,
40%, and 50% fractions of HbA in HbS. Fig. 2 a shows
such a graph for homogeneous nucleation, fo, and Fig. 2 b
shows a graph for B. Error bars are a composite of the
concentration uncertainties and the uncertainties in fo or B.
The solid symbols are the pure HbS from which the model
parameters were derived. Open circles and diamonds are
data at 50% HbA. Up triangles show 30% mixtures, and
down triangles designate 40% composition. As can be
seen, theory and experiment correlate well. It is unexpected
that in one of the two data sets, the homogeneous nucleation
rate is better described than the heterogeneous rate (which is
manifest in B).
Although we collected the data at three fixed ratios of
HbA/HbS and at different concentrations, the success of
the model in describing the results permits a description
of the slowing of the reaction at any concentration, with
continuous variation of the HbA/HbS ratio. We combined
homogeneous and heterogeneous nucleation rates, as well
as growth rates, to obtain delay times as a function of the
fraction of HbA, denoted X, as shown in Fig. 3. The total
concentrations range from 4.5 mM to 6 mM (29–39 g/dl)
in 0.5 mM intervals. The delay times for the highest concen-
trations rise ~100 in going from 0 to 60% HbA, whereas
the lower concentration rises ~1000. The delay times pro-
vide an intuitive measure of the overall reaction rate and
serve as a useful benchmark for understanding the patho-
physiology as described below. Computation of the delay
times also requires knowledge of the fiber growth rate.
Aprelev et al. (25) recently reported experiments that
directly measured this quantity. Their experiments included
AS mixtures, which they successfully modeled by assuming
that hybrids entered the growing polymer with an equilib-
rium probability of 0.357.
The relative increase in delay times depicted in Fig. 3 is
much less than expected based on an earlier study (18). A
similar difference arose when delay times collected from
mixtures of HbS and HbF reported in that work were
compared with those obtained in a more recent study by
Rotter et al. (26). Reconciliation of the data sets has been
described, and the interested reader is referred to the
appendix in the work by Rotter et al. In brief, these differ-
ences derive from two sources: a correction made in the
previous data for a putative contamination by 8% CO, and
the assumption that the temperature dependence of theBiophysical Journal 101(11) 2790–2797
FIGURE 3 Delay times as a function of the fraction of HbA, denoted
X, for 37C. Total concentrations range from 4.5 mM to 6 mM (29.0 m,
32.2 m, 35.4 m, and 38.7 g/dl) in 0.5 mM intervals, going from top to
bottom. The delay time is defined as the time between initiation of the reac-
tion and observation of polymer formation, by linear extrapolation of the
slope of the curve of polymer mass back to the x axis. It provides an intu-
itive measure of the overall reaction rate and serves as as a useful bench-
mark for understanding pathophysiology as described below.
FIGURE 2 Correlation of theory and experiment. Open circles and dia-
monds indicate data at 50% HbA. Up triangles show 30% mixtures, and
down triangles designate 40% composition. The solid symbols are pure
HbS. (a) A graph for homogeneous nucleation, fo. (b) A graph for B. Error
bars are a composite of the concentration uncertainties and the uncertainties
in fo or B.
2794 Rotter et al.delay times was the same for all concentrations, which
was invoked to extrapolate the data to a common set of
conditions.DISCUSSION
Insights into nucleation
Our results provide new insights into the nucleation process.
The need to have a nonhybrid Hb molecule in the nucleus
may be rationalized by the structure of the sickle fibers.Biophysical Journal 101(11) 2790–2797The atomic detail of the fiber structure is only known by
model building in which the known crystal structure
was mapped onto electron microscopy images of fibers
(27,28). This was possible because crystals of HbS have
been resolved to atomic detail by x-ray diffraction, and
revealed staggered double strands consistent with observed
fibers. When polymerization of Hb mutants was studied, it
was found that generally the presence of a mutation site
at a crystal contact would alter the fiber stability (29).
This served as confirmation that the contacts seen in linear
double strands were present in the twisted fibers. One in-
triguing observation was that only one of the two b6 muta-
tions was involved in an intermolecular contact in the
crystal. This explains why copolymerization of HbAS
hybrids is possible at all, but it predicts more HbAS incor-
poration into the fibers than is actually observed. Expressed
as copolymerization probabilities, the crystal double strand
predicts that the probability of a hybrid being present is
0.50, rather than the 0.36 that is deduced from numerous
solubility studies (30). Recently we proposed a modification
of the fiber contacts in which both mutation sites are in-
volved in two of the seven double strands in the fiber (13).
From an examination of Fig. 4, one can understand the
contact regions of the proposed revision. Consider strands
1, 2, 10, and 11. In the standard fiber arrangement (27),
strands 1 and 2 would share a b6 contact, as would 10 and
11. In the proposed revision (13), strands 1 and 11 also share
a b6 contact, necessitating that molecules 1 and 11 now
FIGURE 4 Section through a model 14-stranded sickle fiber. In the stan-
dard fiber arrangement, strands 1 and 2 would share a b6 contact, as would
10 and 11. However, in the Roufberg-Ferrone model (13), strands 1 and 11
also share a b6 contact, necessitating that molecules 1 and 11 must both be
unhybridized HbS. A similar effect occurs between strands 6 and 13.
Nucleation of Sickle Hemoglobin Mixtures 2795must both be unhybridized HbS. This structure successfully
predicted copolymerization probabilities of 0.357, in ex-
cellent agreement with the observations.
The presence of molecules within the fiber that make
contacts using both mutation sites thus supports the plausi-
bility of a similar requirement within a nucleus, although it
does not immediately imply it, because, for example, the
added contacts might be the consequence of a stabilizing
rearrangement once the fibers form, or the final bonds might
be energetically insignificant due to distortions that emerge
when the fiber achieves its energy-minimized structure.
Studies of the nucleation rates of cross-linked hybrid
HbAS molecules showed substantial destabilization of their
nuclei (31). Homogeneous nucleation rates were ~105
slower in cross-linked HbAS, which represents a decrease
of ~8 kcal/mol of stability in the nucleus. This was not due
to the cross-linker, because the cross-linked HbS molecules
used in control experiments showed no such destabilization.
This directly argues that both contact sites, not just one, are
a significant requirement in at least some part of the nucleus.
Clearly, cross-linked hybrids can polymerize, and thus the
lack of such a molecule does not eliminate polymer for-
mation. However, in a solution in which both hybrids and
nonhybrids are present, the nonhybrid pure HbS will be
preferred significantly in one of the sites. The analysis pre-
sented here shows that having one unhybridized molecule
in the homogeneous nucleus is a sufficient requirement.
Moreover, given the location within the polymer of the sites
at which both contacts are employed (cf. Fig. 4), our results
suggest that the polymer nucleus is necessarily off center
from the fiber.
Heterogeneous nucleation requires that the attachment
site have a contact on which to attach an aggregate. It was
proposed (32) and subsequently confirmed (31) that the
attachment site is itself the same contact pair present inthe lateral contact. This minimally requires one additional
pure HbS molecule in the interaction. If the polymer site
is a hybrid, the only way the contact can be made is for
the polymer to contain the acceptor site. This means the
nucleus must have the donor site, and thus the surface mole-
cule must be pure HbS because it requires a second donor
site for internal stability. Conversely, if the nucleus only
has acceptor sites available, having a surface with HbAS
molecules, then the polymer needs to have a donor site,
thus requiring the polymer to have a pure HbS at its surface.
Experimentally, we find this is not sufficient to provide
a satisfactory description of the data, and a net of four non-
hybrid HbS molecules must be present either within the
heterogeneous nucleus or on the surface where the heteroge-
neous nucleus interacts with the fiber. Note that the require-
ment that the entire heterogeneous nucleus be pure HbS is
overly restrictive and does not describe the data either.
The other interesting insight this provides is that the hetero-
geneous nuclei are therefore enriched in HbS.Insights into pathophysiology
The polymerization reaction has long been distinguished by
a pronounced delay observed between initiation and obser-
vation of significant polymer formation (33). This delay is
clinically beneficial because it lets cells escape the narrow
regions of the microcirculation without occlusion, even
though they may eventually become stiff and incompress-
ible in the wider veins (16). The details of the vasoocclusive
process remain incomplete; however, there is significant
support for a step in which cells (erythrocytes or leukocytes)
adherent in the venules play a significant role (15,34). The
consequence of such adhesion is a decreased lumen, which
provides a point of potential obstruction for any erythro-
cytes that have rigidified between their entry into the capil-
laries and the site of postcapillary adhesion. Thus, delay
times that exceed the transit time though the capillaries
and their immediate downstream obstructions will thwart
vasoocclusion. Such a transit time may depend on many
factors, but it is clearly longer than capillary transit (a few
seconds (35)) and is unlikely to be more than ~10 s. Al-
though an interval of 1–10 s might appear to be quite
generous, it must be viewed in the context that delay times
range from milliseconds to hundreds of kiloseconds (19).
Fig. 5 shows the delay time distribution based on measure-
ments of red cells under complete deoxygenation. The range
of cells below 1 s is shaded to indicate that these will surely
sickle in less time than capillary transit times, and the
gradient indicates the transition region to 10 s. The distribu-
tion of intracellular Hb concentrations is taken as Gaussian,
with mean of 31.6 g/dl and a normalized width of 4.1 g/dl.
This distribution is deduced from photolysis measurements
of Coletta et al. (36), whose distribution of cellular delay
times is essentially that shown here, which was inverted to
obtain a distribution of intracellular HbS. This delay timeBiophysical Journal 101(11) 2790–2797
FIGURE 5 Probability of having a cell with a given delay time. All dis-
tributions are computed at 37C based on a Gaussian concentration dis-
tribution deduced by Coletta et al. (36), and assuming instantaneous
deoxygenation. The leftmost distribution is for pure HbS, the center distri-
bution is for 60% HbA, and the rightmost distribution is for 80% HbA,
which approximates 50% desaturation of 60% HbA (trait) cells. The range
of cells below 1 s is shaded to indicate likely sickling in less time than capil-
lary transit times, and the gradient indicates the transition region to 10 s,
which is likely to be longer than any residence time in microcirculation
except for occlusion. The upper limit of delay times has been taken as
104 s, which is ~3 min, or just longer than full circulation times. Very
few cells in the rightmost distribution will sickle in the microvasculature,
whereas moving to full deoxygenation drastically increases that fraction,
suggesting how extreme exertion can lead to catastrophic effects on sickle
trait patients.
2796 Rotter et al.distribution and the subsequent distributions described
below all assume immediate deoxygenation, and a more
gradual process spread over the transit time would skew
the distributions away from the shortest times (37). A
second feature that is not contained in this simulation is
the presence of stochastic variation of the delay times longer
than seconds (38). This would extend the long tail of the
distribution. The upper limit of delay times has been taken
as 104 s, which is ~3 min, or just longer than full circulation
times.
Sickle trait individuals typically have ~60% HbA (7). The
results presented here (Fig. 3) allow us to examine the shift
in the delay time distribution for such individuals relative to
individuals with sickle cell anemia, again in the case of
complete deoxygenation. Fig. 5 shows the delay time distri-
bution for the same concentration distribution shown above
assuming a uniform distribution of 60% HbA. The distribu-
tion is the center one shown. It is clearly shifted well to the
right of the HbS delay time distribution. Whereas for HbS
most cells would have sickled inside the critical transit
time, now the fraction is much less. This prediction agrees
well with the sparse available data. Zarkowsky et al. (39)Biophysical Journal 101(11) 2790–2797measured delay time distributions on trait individuals by
using dithionite mixing to induce deoxygenation. The loca-
tion of the peak from their measurements agrees closely
with the distribution projected here. Note that it is assumed
that the intracellular distribution of Hb is the same in both
cases, and the degree of similarity may be less than assumed
in comparing trait individuals with sicklers (7).
The condition of complete deoxygenation portrayed
in these two distributions is extraordinary, however, and,
most commonly, cells will only deliver about half of their
oxygen (40). Although to date there has been no systematic
study of the nucleation process in the presence of ligands,
the behavior of half-saturated HbS is similar to that of
50% HbA. Indeed, in a recent study we showed that fiber
growth rates are the same for 50% deoxygenation and
50% HbA (25). We can therefore use the results reported
here to estimate how the distribution of delay times for
full deoxygenation would be transformed under the more
physiological situation of half saturation. An exact calcula-
tion is beyond the scope of this work, but we shall approx-
imate the case of partial saturation and sickle trait as a
mixture equivalent to 80% HbA, 20% HbS. This is based
on the approximation that a 40% HbS solution with 50%
deoxygenation contains ~20% polymerization-competent
molecules. Using an 80:20 mixture gives the rightmost
distribution in Fig. 5. For this distribution, very few cells
will sickle in <10 s, and almost none will do so in <1 s.
This figure therefore gives insight into the case of trait
individuals who have been affected by extreme exertion.
The deoxygenation level in such individuals would be
pushed to a lower fractional saturation, perhaps approaching
zero. In such conditions the far right distribution moves left
to the center one, and instead of having virtually no cells
sickling, an occlusive fraction now reappears. It is this
process that we would associate with cases in which intense
training or exercise has proven harmful or fatal. This would
suggest that even simple monitoring of oxygen saturation
under venous conditions might prove useful for warning in-
dividuals about such impending catastrophic events.
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